MRSH trades 14.6% below Wall Street's consensus target of $199.40.
Last 12 months price action with 12-month analyst target path
The base valuation assumes MRSH achieves its forward estimates and maintains a stable P/E multiple of 16.9x. This scenario reflects the blended consensus of 26 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 8, 2026, Marsh & McLennan Companies, Inc. (MRSH) has a Wall Street consensus price target of $199.40, based on estimates from 26 covering analysts. With the stock currently trading at $204.82, this represents a potential upside of +14.6%. The company has a market capitalization of $97.74B.
Analyst price targets range from a low of $135.00 to a high of $257.00, representing a 61% spread in expectations. The median target of $199.50 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Hold, with 8 analysts rating the stock as a Buy or Strong Buy,17 rating it Hold, and 1 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, MRSH trades at a trailing P/E of 24.3x and forward P/E of 16.9x. The forward PEG ratio of 0.88 suggests the stock may be undervalued relative to its growth. Analysts expect EPS to grow +23.4% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $231.37, with bear and bull scenarios of $145.76 and $304.85 respectively. Model confidence stands at 55/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 AONAon plc | $71.0B | $334.81 | $361.30 | +7.9% | Buy | 18.2x | 38 |
 WTWWillis Towers Watson Public Limited Company | $31.1B | $328.86 | $358.11 | +8.9% | Buy | 16.6x | 29 |
 AJGArthur J. Gallagher & Co. | $72.3B | $281.61 | $284.92 | +1.2% | Buy | 21.5x | 29 |
 BROBrown & Brown, Inc. | $24.1B | $72.12 | $72.67 | +0.8% | Hold | 16.3x | 31 |
 MCOMoody's Corporation | $87.6B | $505.67 | $536.44 | +6.1% | Buy | 30.1x | 32 |
 SPGIS&P Global Inc. | $137.9B | $467.80 | $512.14 | +9.5% | Buy | 26.1x | 28 |
 HWCHancock Whitney Corporation | $5.8B | $71.48 | $83.33 | +16.6% | Buy | 11.1x | 25 |
 RYANRyan Specialty Holdings, Inc. | $12.5B | $47.73 | $48.50 | +1.6% | Buy | 21.9x | 19 |
 ERIEErie Indemnity Company | $12.6B | $273.07 | — | — | — | 21.2x | — |
 EGEverest Group, Ltd. | $15.5B | $411.11 | $411.00 | -0.0% | Hold | 7.5x | 23 |
Quick answers to the most common questions about buying MRSH stock.
Marsh & McLennan Companies, Inc. (MRSH) has a consensus 12-month price target of $199.4, implying 14.6% upside from $204.82. The 26 analysts covering MRSH see moderate appreciation potential.
MRSH has a consensus rating of "Hold" based on 26 Wall Street analysts. The rating breakdown is mixed, with 17 Hold ratings making up the largest segment. The consensus 12-month price target of $199.4 implies 14.6% upside from current levels.
With a forward P/E of 16.8851x, MRSH trades at a relatively low valuation. The consensus target of $199.4 implies 14.6% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $257 for MRSH, while the most conservative target is $135. The consensus of $199.4 represents the median expectation. Our quantitative valuation model projects a bull case target of $305 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
MRSH is heavily covered by Wall Street, with 26 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 8 have Buy ratings, 17 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month MRSH stock forecast based on 26 Wall Street analysts shows a consensus price target of $199.4, with estimates ranging from $135 (bear case) to $257 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $231, with bear/bull scenarios of $146/$305.
Our quantitative valuation model calculates MRSH's fair value at $231 (base case), with a bear case of $146 and bull case of $305. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 55/100.
MRSH trades at a forward P/E ratio of 16.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 24.3x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are optimistic on MRSH, with a "Hold" consensus rating and $199.4 price target (14.6% upside). 8 of 26 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
MRSH analyst price targets range from $135 to $257, a 61% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $199.4 consensus represents the middle ground. Our model's $146-$305 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.